Correlation Between NRx Pharmaceuticals and Candel Therapeutics
Can any of the company-specific risk be diversified away by investing in both NRx Pharmaceuticals and Candel Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining NRx Pharmaceuticals and Candel Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between NRx Pharmaceuticals and Candel Therapeutics, you can compare the effects of market volatilities on NRx Pharmaceuticals and Candel Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in NRx Pharmaceuticals with a short position of Candel Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of NRx Pharmaceuticals and Candel Therapeutics.
Diversification Opportunities for NRx Pharmaceuticals and Candel Therapeutics
0.07 | Correlation Coefficient |
Significant diversification
The 3 months correlation between NRx and Candel is 0.07. Overlapping area represents the amount of risk that can be diversified away by holding NRx Pharmaceuticals and Candel Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Candel Therapeutics and NRx Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on NRx Pharmaceuticals are associated (or correlated) with Candel Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Candel Therapeutics has no effect on the direction of NRx Pharmaceuticals i.e., NRx Pharmaceuticals and Candel Therapeutics go up and down completely randomly.
Pair Corralation between NRx Pharmaceuticals and Candel Therapeutics
Assuming the 90 days horizon NRx Pharmaceuticals is expected to generate 3.14 times more return on investment than Candel Therapeutics. However, NRx Pharmaceuticals is 3.14 times more volatile than Candel Therapeutics. It trades about 0.06 of its potential returns per unit of risk. Candel Therapeutics is currently generating about 0.07 per unit of risk. If you would invest 30.00 in NRx Pharmaceuticals on September 12, 2024 and sell it today you would lose (23.41) from holding NRx Pharmaceuticals or give up 78.03% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Insignificant |
| Accuracy | 82.83% |
| Values | Daily Returns |
NRx Pharmaceuticals vs. Candel Therapeutics
Performance |
| Timeline |
| NRx Pharmaceuticals |
| Candel Therapeutics |
NRx Pharmaceuticals and Candel Therapeutics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with NRx Pharmaceuticals and Candel Therapeutics
The main advantage of trading using opposite NRx Pharmaceuticals and Candel Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if NRx Pharmaceuticals position performs unexpectedly, Candel Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Candel Therapeutics will offset losses from the drop in Candel Therapeutics' long position.| NRx Pharmaceuticals vs. NRX Pharmaceuticals | NRx Pharmaceuticals vs. Relief Therapeutics Holding | NRx Pharmaceuticals vs. Quantum Si incorporated | NRx Pharmaceuticals vs. Reviva Pharmaceuticals Holdings |
| Candel Therapeutics vs. Aerovate Therapeutics | Candel Therapeutics vs. Adagene | Candel Therapeutics vs. Acrivon Therapeutics, Common | Candel Therapeutics vs. Rezolute |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Equity Analysis module to research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities.
Other Complementary Tools
| Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios | |
| Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets | |
| Bonds Directory Find actively traded corporate debentures issued by US companies | |
| Technical Analysis Check basic technical indicators and analysis based on most latest market data | |
| Sign In To Macroaxis Sign in to explore Macroaxis' wealth optimization platform and fintech modules |